SD
Srikripa Devarakonda Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.7%
Neutral
23.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $55 |
19%
upside
| 2 | +31% |
0
%
| 4 Mar ‘26 yesterday |
|
|
|
Hold
Maintained
| $193 |
3%
upside
| 3 | +57% |
0
%
| 9 Feb ‘26 24 days ago |
|
|
|
Buy
Maintained
| $92 |
48%
upside
| 1 | -4.5% |
0
%
| 3 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $110 |
21%
upside
| 3 | +18% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Buy
Initiated
| $34 |
27%
upside
| 1 | +5.6% |
0
%
| 15 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $116 |
41%
upside
| 3 | +14% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $56 |
36%
upside
| 4 | +55% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $640 |
46%
upside
| 2 | +3.1% |
0
%
| 19 Nov ‘25 3 months ago |
|
|
|
Hold
Reiterated
| $93 |
4%
downside
| 4 | – |
–
| 29 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $15 |
4%
upside
| 1 | +46% |
0
%
| 15 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $50 |
62%
upside
| 1 | +127% |
0
%
| 15 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $812 |
7%
upside
| 3 | +11% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $11 |
19%
downside
| 1 | – |
–
| 5 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $25 |
114%
upside
| 1 | +22% |
0
%
| 9 Apr ‘25 11 months ago |
|